HIF1A and type 2 diabetes mellitus: Specifically, pharmacologic reversal of HIF-1 inhibition through the inhibition of prolyl hydroxylases (PHDs) in diabetic hearts was shown to improve cardiac recovery following an ischemic event in a model of type 2 diabetes in rats [23].